Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma

Chemotherapy

Volumn 55, Issue 5, 2009, Pages 312-320

  Hua, Yun Peng ^a   Yin, Xiao Yu ^a   Peng, Bao Gang ^a   Li, Shao Qiang ^a   Lai, Jia Ming ^a   Liang, Hui Zhen ^a   Liang, Li Jian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Somatostatin; Somatostatin receptor 2

Indexed keywords

OCTREOTIDE; SOMATOSTATIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PREVENTION; CELL CYCLE; CELL PROLIFERATION; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER CELL; LIVER CELL CARCINOMA; LONG TERM CARE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MICE; MICE, NUDE; OCTREOTIDE; RATS; RECEPTORS, SOMATOSTATIN; TRANSPLANTATION, HETEROLOGOUS;

EID: 67649859237     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227763     Document Type: Article

References (26)

1. Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003;362:1907-1917.
2. Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A, Roda E: Hepatocellular carcinoma prevention: a world-wide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol 2006;12:7239-7249. (Pubitemid 44911828)
3. Kao JH, Chen DS: Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia. Liver Int 2005;25:696-703.
4. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ: Octreotide. N Engl J Med 1996;334:246-254.
5. Cascinu S, Del Ferro E, Ligi M, Staccioli MP, Giordani P, Catalano V, Agostinelli R, Muretto P, Catalano G: Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients. Cancer Invest 2001;19:8-12. (Pubitemid 32233796)
6. Casini Raggi C, Calabrò A, Renzi D, Briganti V, Cianchi F, Messerini L, Valanzano R, Cameron Smith M, Cortesini C, Tonelli F, Serio M, Maggi M, Orlando C: Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa. Clin Cancer Res 2002;8:419-427. (Pubitemid 34193959)
7. Jia WD, Xu GL, Xu RN, Sun HC, Wang L, Yu JH, Wang J, Li JS, Zhai ZM, Xue Q: Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts. J Cancer Res Clin Oncol 2003;129:327-334. (Pubitemid 36963194)
8. Schmid HP, Gregorin J, Altwein JE: Growth hormone inhibitors in prostate cancer: a systematic analysis. Urol Int 2008;81:17-22.
9. Zou Y, Xiao X, Li Y, Zhou T: Somatostatin analogues inhibit cancer cell proliferation in an SSTR2-dependent manner via both cytostatic and cytotoxic pathways. Oncol Rep 2009;21:379-386.
10. Liu HL, Huo L, Wang L: Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells. Acta Pharmacol Sin 2004;25:1380-1386. (Pubitemid 39361813)
11. Quan ZW, Yue JN, Li JY, Qin YY, Guo RS, Li SG: Somatostatin elevates topoisomerase II alpha and enhances the cytotoxic effect of doxorubicin on gallbladder cancer cells. Chemotherapy 2008;54:431-437.
12. Zhou T, Xiao X, Xu B, Li H, Zou Y: Overexpression of SSTR2 inhibited the growth of SSTR2-positive tumors via multiple signaling pathways. Acta Oncol 2008;47:1-10.
13. Li M, Wang X, Li W, Li F, Yang H, Wang H, Brunicardi FC, Chen C, Yao Q, Fisher WE: Somatostatin receptor-1 induces cell cycle arrest and inhibits tumor growth in pancreatic cancer. Cancer Sci 2008;99:2218-2223.
14. Barresi V, Alafaci C, Salpietro F, Tuccari G: SSTR2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density? Eur J Endocrinol 2008;159:475-482.
15. Xie YM, Yan LN, Wei B, Guo MM, Tang CW: Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration. Ai Zheng 2007;26:688-692.
16. Wang F, Wang Z, Wu J, Qu W, Yao W, Zhao J, Liu Z: The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR. Nucl Med Biol 2008;35:665-671.
17. Taboada GF, Luque RM, Neto LV, Machado Ede O, Sbaffi BC, Domingues RC, Marcondes JB, Chimelli LM, Fontes R, Niemeyer P, de Carvalho DP, Kineman RD, Gadelha MR: Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR. Eur J Endocrinol 2008;158:295-303.
18. Reynaert H, Rombouts K, Vandermonde A, Urbain D, Kumar U, Bioulac-Sage P, Pinzani M, Rosenbaum J, Geerts A: Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma. Gut 2004;53:1180-1189. (Pubitemid 38961975)
19. 2 receptor and activation of extracellular signal-regulated kinases are dynamin-dependent. J Neurochem 2008;107:208-217.
20. Hendriks-Balk MC, Peters SL, Michel MC, Alewijnse AE: Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins. Eur J Pharmacol 2008;585:278-291.
21. Beaumont V, Hepworth MB, Luty JS, Kelly E, Henderson G: Somatostatin receptor desensitization in NG108-15 cells. J Biol Chem 1998;273:33174-33183.
22. Liu Q, Reubi JC, Wang Y, Knoll BJ, Schonbrunn A: In vivo phosphorylation of the somatostatin 2A receptor in human tumors. J Clin Endocrinol Metab 2003;88:6073-6079.
23. Ma Y, Hua YP, Chen ZB, Zhang JX: Induction of chemical hepatocarcinogenesis and establishment of orthotopic liver transplantation model with hepatocarcinoma in rat. Natl Med J Chin 2006;86:850-853.
24. Shen H: The study of immunohistochemical quantitative method (III). Chin J Histochem Cytochem 1995;4:89-91.
25. Boudin H, Sarret P, Mazella J, Schonbrunn A, Beaudet A: Somatostatin-induced regulation of SST2A receptor expression and cell surface availability in central neurons: role of receptor internalization. J Neurosci 2000;20:5932-5939. (Pubitemid 30658384)
26. Hukovic N, Rocheville M, Kumar U, Sasi R, Khare S, Patel YC: Agonist-dependent upregulation of human somatostatin receptor type 1 requires molecular signals in the cytoplasmic C-tail. J Biol Chem 1999;274:24550-24558. (Pubitemid 129529333)